Today: 12 March 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Northern Star Resources stock: NST share price edges up as Jan 22 cost update nears

Northern Star Resources stock: NST share price edges up as Jan 22 cost update nears

Northern Star Resources shares closed up 0.8% at A$25.15 after last week’s production guidance cut and a December quarter hit by a crusher failure at KCGM. The miner reported first-half gold sales of about 729,000 ounces and will update cost guidance with its Jan. 22 results. The stock remains 6% below its Dec. 31 close. Gold prices rose 0.5% to $4,469.96 an ounce.
6 January 2026
··
Westpac shares slide 2.2% as bank sell-off deepens ahead of Australia CPI test

Westpac shares slide 2.2% as bank sell-off deepens ahead of Australia CPI test

Westpac shares fell 2.2% to A$38.19 on Tuesday, with about 4 million shares traded, as investors braced for an inflation report due Wednesday. The decline tracked losses across major Australian banks and followed a 0.5% drop in the S&P/ASX 200. Money markets priced a 33% chance of a February rate hike after recent inflation data. Westpac’s first-quarter results are set for February 13.
6 January 2026
·····
IndusInd Bank’s loan slump deepens: Q3 update shows advances down 13% and CASA sliding

IndusInd Bank’s loan slump deepens: Q3 update shows advances down 13% and CASA sliding

IndusInd Bank’s net advances fell 13% year-on-year to 3.18 trillion rupees as of December 31, marking a fourth straight quarterly decline. Deposits dropped 3.8% from a year earlier but rose 1.1% from September; the CASA ratio slipped to 30.3%. The bank’s loan contraction contrasts with double-digit growth at larger rivals. IndusInd is recovering from a $230 million derivatives misaccounting scandal.
6 January 2026
NAB slides nearly 3% as rate-hike chatter hits bank stocks ahead of Australia inflation print

NAB slides nearly 3% as rate-hike chatter hits bank stocks ahead of Australia inflation print

National Australia Bank shares fell 3.0% to A$41.28 on Tuesday, underperforming the market as traders braced for Wednesday’s CPI data. Australia’s benchmark index slipped 0.92%, with financials among the main drags. Investors recalibrated for the risk of the Reserve Bank of Australia keeping rates higher for longer. NAB’s next trading update is set for February 18.
6 January 2026
··
Macquarie shares buck weak ASX as investors eye Qube deadline and May results

Macquarie shares buck weak ASX as investors eye Qube deadline and May results

Macquarie Group shares rose 1.68% to A$206.76 Tuesday, outperforming the S&P/ASX 200, which fell 0.52%. The stock touched a high of A$207.08 as investors watched for updates on its Qube bid, with the exclusivity deadline set for February 1. No new company filings were posted in the past two days. Macquarie last reported a 3% rise in first-half net profit to A$1.66 billion in November.
6 January 2026
···
BlueScope Steel stock jumps 21% on A$30 takeover bid — the next catalyst investors are watching

BlueScope Steel stock jumps 21% on A$30 takeover bid — the next catalyst investors are watching

BlueScope Steel shares jumped 20.6% to A$29.48 after SGH and Steel Dynamics made a non-binding A$30-per-share takeover offer. The proposal, received Dec. 12, is subject to due diligence, exclusivity, and other conditions. BlueScope’s board is reviewing the bid against its own valuation. The company previously rejected lower offers, citing execution risks.
6 January 2026
···
DroneShield stock jumps 18% as ASX:DRO taps Louis Gamarra as chief commercial officer

DroneShield stock jumps 18% as ASX:DRO taps Louis Gamarra as chief commercial officer

DroneShield shares surged 18.1% to A$3.91 in Sydney on Tuesday, with turnover more than doubling to 32 million shares. The company named Louis Gamarra chief commercial officer to lead global sales. The rally lifted the stock 27% above its Dec. 31 close, even as the broader ASX 200 fell 0.5%. Investors await the next earnings update for signs of sustained demand.
6 January 2026
··
Legend Biotech stock hits a fresh 52-week low as biotech lags — JPMorgan update looms

Legend Biotech stock hits a fresh 52-week low as biotech lags — JPMorgan update looms

Legend Biotech shares dropped 4.7% to $20.49 Monday, hitting a 52-week low and leaving the stock down 55% from its high. The decline comes ahead of the J.P. Morgan Healthcare Conference, where CEO Ying Huang is set to present Jan. 14. Broader biotech stocks also fell, with key ETFs down about 1%. Investors are watching for updates on CARVYKTI, Legend’s CAR-T therapy for multiple myeloma.
5 January 2026
·
Sanmina stock slides after early pop as manufacturing data, peer moves hit sentiment

Sanmina stock slides after early pop as manufacturing data, peer moves hit sentiment

Sanmina shares fell 5.1% to $151.12 Monday after an early rally above $165 faded, underperforming as Wall Street hit record highs. Electronics manufacturing peers Jabil, Flex, and Celestica also dropped, pressured by weak U.S. manufacturing data and Jabil’s acquisition of Hanley Energy. Investors are awaiting Friday’s U.S. jobs report and Sanmina’s upcoming earnings window.
5 January 2026
·
1 … 299 300 301 302 303 … 584

Stock Market Today

  • Zumiez Q4 2025 Revenue Beats Estimates Despite Stock Drop
    March 12, 2026, 5:47 PM EDT. Zumiez (NASDAQ:ZUMZ) reported Q4 CY2025 revenue of $291.3 million, up 4.4% year-on-year and 0.8% above analyst estimates. GAAP EPS rose 8.9% above expectations to $1.16 per share. Adjusted EBITDA reached $37.43 million, a 25.6% beat, driven by strong sales in North America and improved product margins in Europe. Revenue guidance for Q1 CY2026 stands at $191 million, 2.5% higher than forecasts, though EPS guidance of -$0.82 missed estimates by 9.3%. Operating margin expanded to 8.6% from 7.2% the previous year. Zumiez ended the quarter with 716 stores, down from 730 a year earlier, and same-store sales increased 2.2%. CEO Rick Brooks highlighted progress in merchandise and expense management amid ongoing efforts to drive growth and shareholder value.
Go toTop